11.4%
Revenue Growth
MCK achieved an 11.4% increase in revenue, driven by strong demand across its product lines.
Source: Source: 10-Q Income Statement, p.1
AI Takeaway
MCK reported strong financial performance in Q3 FY2026, with significant increases in revenue, operating income, and net income, despite ongoing cost pressures.
Revenue
$106.16B
++11.40% YoY
EPS (Basic)
$9.63
++37.97% YoY
Gross Margin
3.5%
++0.03% YoY
Operating Income
$1.62B
++32.27% YoY
Filed · Analysis updated · Source: SEC EDGAR 10-Q filing
MCK achieved an 11.4% increase in revenue, driven by strong demand across its product lines.
Source: Source: 10-Q Income Statement, p.1
Operating income rose by 32.3%, reflecting improved operational efficiencies and cost management.
Source: Source: 10-Q Income Statement, p.1
Operating cash flow turned positive at $2.73B, indicating enhanced cash generation capabilities.
Source: Source: 10-Q Cash Flow, p.1
MCK's long-term debt increased by 17.4% to $6.56B, which could pressure future cash flows if interest rates rise.
Source: Source: 10-Q Balance Sheet, p.1
Unlock 2 more detailed risk analysis
Upgrade to unlockReported EPS of $9.34 versus the $9.31 analyst consensus — a +0.3% beat for Q3 FY2026.
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $106.16B | $95.29B | +11.40% |
Cost of Revenue | $102.47B | $92.01B | +11.37% |
Gross Profit | $3.69B | $3.28B | +12.21% |
Operating Income | $1.62B | $1.22B | +32.27% |
Net Income | $1.19B | $879M | +34.93% |
EPS (Basic) | $9.63 | $6.98 | +37.97% |
EPS (Diluted) | $9.59 | $6.95 | +37.99% |
SG&A Expense | $2.03B | $2.03B | +0.10% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $84.19B | $71.08B | +18.44% |
Current Assets | $59.7B | $51.74B | +15.38% |
Current Liabilities | $68.13B | $58.56B | +16.34% |
Stockholders' Equity | $-1.3B | $-3.08B | +57.91% |
Cash & Equivalents | $2.96B | $1.13B | +161.63% |
Long-Term Debt | $6.56B | $5.59B | +17.36% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash FlowYTD | $2.73B | $-1.66B | +264.40% |
Investing Cash FlowYTD | $-3.86B | $-509M | -657.76% |
Financing Cash FlowYTD | $-1.81B | $-1.11B | -63.15% |
Share BuybacksYTD | $2.08B | $2.85B | -26.95% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 3.5% | 3.4% | +0.03% |
Operating Margin | 1.5% | 1.3% | +0.24% |
Net Margin | 1.1% | — | — |
ROE | -91.4% | — | — |
ROA | 1.4% | — | — |
Current Ratio | $0.876 | — | — |
Other companies in Health Care Distributors
MCK reported a 38.0% increase in EPS to $9.63, indicating strong earnings performance, but specific estimates are not provided.
Key takeaways include an 11.4% revenue increase, a 34.9% rise in net income, and improved operating cash flow, despite liquidity challenges.
MCK's revenue grew by 11.4% YoY to $106.16B, driven by strong demand across its product lines.
Risks include high debt levels, negative equity, and a low current ratio, which could impact financial flexibility.
MCK shows strong revenue and income growth but faces challenges with liquidity and debt levels, as indicated by a current ratio of 0.88.